The Future of Radiopharmaceuticals | Christopher P. Leamon | CANM'23

Christopher P. Leamon provides an industry perspective on next-generation radiopharmaceuticals, focusing on the development and potential of alpha therapy. This enlightening presentation from the Canadian Association of Nuclear Medicine Conference delves into how industry advancements are shaping the future of therapeutic radiology. A must-watch for professionals and researchers in nuclear medicine.